Cards (5)

  • comparison of penem and carbapenem
    • carbon has about half the diameter as that of sulfur
    • carbopenem ring thus is more strained than the penem ring
    • the fused beta lactam ring is thus more reactive and potent against PBPs
    • carbopenem is also less stable and easier to be hydrolyzed, thus prohibiting oral bioavailability
  • thienamycin
    • not a real drug but the lead compound of carbapenem antibiotics
    • attractive properties:
    • extremely potent in vitro
    • broad-spectrum antimicrobial activity in vitro
    • very stable and even inhibitor to beta-lactamase d/t the alpha-oriented hydroxyethyl group
    • penetrates through porin (small zwitter ion)
    • shortcomings:
    • very unstable at acidic or alkaline pHs
    • concentration-dependent self-inactivation of beta-lactam ring in solution by the primary amine
    • hydrolysis by renal dehydropeptidase-I
    • half-life too short to be useful in vivo
  • imipenem + silastatin (primaxin): a "precious", "reserved" antibiotics
    • improvements from thienamycin:
    • the primary amine group is replaced w/ a non-nucleophilic imine group
    • long enough plasma half-life (~ 1h) d/t the inhibition of renal dehydropeptidase-I by cilastatin
    • activities and clinical applications:
    • broader spectrum than any available antibiotics in US
    • orally inactive
    • induces the expression of beta-lactamase
    • seldom the first line drug but a reserved parenteral drug for special cases of serious infection
  • second-generation carbapenems
    • meropenem (merrem)
    • used for about 10 yrs to treat CNS infections
    • also approved for complicated skin infections
    • stable to and even inhibitor to most beta-lactamases
    • small zwitter ions and penetrates through porins well
    • intrinsically stable to renal dehydropeptidase-I and is used alone
    • potent and broad-spectrum
    • "precious" antibiotic drugs usually reserved for serious hospital acquired infections that are resistant to other beta-lactams
  • ertapenem (invanz)
    • one additional negative charge compared w/ other carbapenems
    • a longer serum half-life that allows once-daily dosing
    • inferior activity against gram negative P. aeruginosa and Acinetobacter spp.
    • its spectrum of activity against gram positive organisms, Enterobacteriaceae, and anaerobes makes it attractive for use in intra-abdominal and pelvic infections